(Q51311643)

3 April 2018

title

High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level. (English)

1 reference

3 April 2018

author name string

Chunsen Xu

1

1 reference

3 April 2018

Mutsuko Yamamoto-Ibusuki

2

1 reference

3 April 2018

Yutaka Yamamoto

3

1 reference

3 April 2018

Satoko Yamamoto

4

1 reference

3 April 2018

Saori Fujiwara

5

1 reference

3 April 2018

Keiichi Murakami

6

1 reference

3 April 2018

Yasuhiro Okumura

7

1 reference

3 April 2018

Lisa Yamaguchi

8

1 reference

3 April 2018

Yoshitaka Fujiki

9

1 reference

3 April 2018

Hirotaka Iwase

10

1 reference

3 April 2018

publication date

12 September 2012

1 reference

3 April 2018

published in

Breast Cancer

1 reference

3 April 2018

volume

21

1 reference

3 April 2018

issue

4

1 reference

3 April 2018

page(s)

482-490

1 reference

3 April 2018

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

ACP Journal Club. Review: In women 39 to 69 years of age, screening with mammography reduces breast cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Advances in breast cancer: pathways to personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (< or = 1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

New wirings in the survivin networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Survivin as a global target of intrinsic tumor suppression networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Prognostic importance of survivin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Adjuvant strategies in breast cancer: new prospectives, questions and reflections at the end of 2007 St Gallen International Expert Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Comparison of mRNA and protein measures of cytokines following vaccination with human papillomavirus-16 L1 virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Discordant protein and mRNA expression in lung adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Regulation of survivin function by Hsp90

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

Acetylation Directs Survivin Nuclear Localization to Repress STAT3 Oncogenic Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0403-9

10.1007/S12282-012-0403-9

21 January 2018

Identifiers

DOI

1 reference

3 April 2018

1 reference

3 April 2018